logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2011 or most recent year available

Part (vi) New volatile inhalant outpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium23000001606
Bulgaria00000000000
Czech Republic02000100303
Denmark01000001202
Germany9834200026026
Estonia41000000505
Ireland18602100017017
Greece01000010202
Spain134340100253053
France15115602232032
Italy200008000808
Cyprus00000000000
Latvia39400000013013
Lithuania11100010404
Luxembourg:::::::::::
Hungary0641210014014
Malta:::::::::::
Netherlands02200102707
Austria00000000000
Poland4:::::::::::
Portugal500010000101
Romania01010000202
Slovenia:::::::::::
Slovakia43200000909
Finland01000000101
Sweden101000000101
United Kingdom68175211377662160216
Croatia:::::::::::
Turkey:::::::::::
Norway:::::::::::
Total1221644827271010144220422
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-10 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

For more information relative to the treatment centre type, please see Table TDI-7.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

Page last updated: Friday, 26 April 2013